Lucy Therapeutics

About:

Lucy Therapeutics develops treatments for mitochondrial diseases and neurodegenerative disorders by targeting mitochondrial proteins.

Website: https://www.lucytherapeutics.com

Twitter/X: lucytherapeutix

Top Investors: Massachusetts Life Sciences Center, Engine Ventures, The Engine, Michael J. Fox Foundation, Safar Partners

Description:

Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria. The company is offering a differentiated approach to drug discovery by drugging targets associated with early disease pathogenesis. The company's approach can also be expanded to provide new options for treating similar neurologically focused diseases including Parkinson's Disease (PD) and Alzheimer's Disease (AD).

Total Funding Amount:

$38.5M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)lucytherapeutics.com

Founders:

Amy Ripka

Number of Employees:

101-250

Last Funding Date:

2024-05-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai